Ownership history in ORBIMED ADVISORS LLC Β· 13 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in DISC MEDICINE INC (IRON). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π ORBIMED ADVISORS LLC outperformed the S&P 500 by +46.9% annually on this IRON position. Timing score: 50% (2/4 decisions correct). Average cost basis: $31.55. Maximum drawdown during holding period: β27.6%.
π₯ Exceptional β beat the S&P 500 by 46.9% per year on this position.
11 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
2 of 4 add/trim decisions correct
Best entry: $21.19 (2023 Q1) Β· Worst: $45.07 (2024 Q2)
πͺ Held through 2 major drawdowns (>20%).
3 adds Β· 3 trims. Bought during 1 of 2 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 1.73% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size